EGFR activation limits the response of liver cancer to lenvatinib
Haojie Jin(Shanghai Jiao Tong University), Yao Shi(Shanghai Jiao Tong University), Yuanyuan Lv(Shanghai Jiao Tong University), Shengxian Yuan(Second Military Medical University), Christel Ramirez(The Netherlands Cancer Institute), Cor Lieftink(The Netherlands Cancer Institute), Liqin Wang(The Netherlands Cancer Institute), Siying Wang(Shanghai Jiao Tong University), Cun Wang(Shanghai Jiao Tong University), Matheus Henrique Dias(The Netherlands Cancer Institute), Fleur Jochems(The Netherlands Cancer Institute), Yuan Yang(Second Military Medical University), Astrid Bosma(The Netherlands Cancer Institute), E. Marielle Hijmans(The Netherlands Cancer Institute), Marnix H. P. de Groot(The Netherlands Cancer Institute), Serena Vegna(The Netherlands Cancer Institute), Dan Cui(Shanghai Jiao Tong University), Yangyang Zhou(Shanghai Jiao Tong University), Ling Jing(Shanghai Jiao Tong University), Hui Wang(Shanghai Jiao Tong University), Yuchen Guo(Shanghai Jiao Tong University), Xingling Zheng(Shanghai Jiao Tong University), Nikita Isima(The Netherlands Cancer Institute), Hai-Qiu Wu(Leiden University Medical Center), Chong Sun(German Cancer Research Center), Roderick L. Beijersbergen(The Netherlands Cancer Institute), Leila Akkari(The Netherlands Cancer Institute), Weiping Zhou(Second Military Medical University), Bo Zhai(Shanghai Jiao Tong University), Wenxin Qin(Shanghai Jiao Tong University), René Bernards(The Netherlands Cancer Institute)
Cited by 428
Abstract
Related Papers
No related papers found
Powered by citation graph analysis